D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 112 Citations 61,385 624 World Ranking 2921 National Ranking 114

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Steven Gallinger mainly investigates Internal medicine, Pancreatic cancer, Cancer, Oncology and Germline mutation. Many of his studies on Internal medicine apply to Gastroenterology as well. His research integrates issues of Genome-wide association study, CDKN2A, Pancreatic disease and Bioinformatics in his study of Pancreatic cancer.

Steven Gallinger is interested in MSH2, which is a field of Cancer. The Oncology study combines topics in areas such as Breast cancer, Prospective cohort study and Adenocarcinoma. His Germline mutation research incorporates themes from Penetrance, Lynch syndrome, Genetic testing and Risk factor.

His most cited work include:

  • Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (3088 citations)
  • DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy (358 citations)
  • Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer (328 citations)

What are the main themes of his work throughout his whole career to date?

Steven Gallinger spends much of his time researching Internal medicine, Colorectal cancer, Oncology, Cancer and Genetics. His research in Internal medicine intersects with topics in Gastroenterology and Microsatellite instability. His Colorectal cancer research is multidisciplinary, relying on both MUTYH, Surgery and Disease, Pathology.

His Oncology research includes themes of Gene mutation, DNA mismatch repair, Family history, Cohort and Adenocarcinoma. His work deals with themes such as Gynecology and Epidemiology, which intersect with Cancer. His Pancreatic cancer study combines topics from a wide range of disciplines, such as Transcriptome, Cancer research, CDKN2A and Bioinformatics.

He most often published in these fields:

  • Internal medicine (51.82%)
  • Colorectal cancer (41.25%)
  • Oncology (39.77%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (51.82%)
  • Oncology (39.77%)
  • Colorectal cancer (41.25%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Oncology, Colorectal cancer, Cancer and Pancreatic cancer are his primary areas of study. His biological study spans a wide range of topics, including Lynch syndrome, DNA mismatch repair, Microsatellite instability, KRAS and Cohort. His Colorectal cancer research is multidisciplinary, incorporating perspectives in Genome-wide association study, Epidemiology, Case-control study, Genotype and Family history.

His Cancer research incorporates elements of False positive paradox, Multiplex, Proteomics, Immunoassay and DNA repair. The various areas that Steven Gallinger examines in his Pancreatic cancer study include Cancer research, Malignancy, GATA6 and Adenocarcinoma. The concepts of his Cancer research study are interwoven with issues in Phenotype, Gene, Mutation, Transcriptome and PALB2.

Between 2018 and 2021, his most popular works were:

  • Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa (208 citations)
  • Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (96 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Internal medicine, Pancreatic cancer, Oncology, Cancer and Colorectal cancer are his primary areas of study. His Internal medicine study focuses on Chemotherapy in particular. His Pancreatic cancer research integrates issues from Cancer research, Malignancy, GATA6, KRAS and Gene.

His Oncology study combines topics in areas such as FOLFIRINOX, In situ hybridization, Gene expression profiling, Biopsy and Cohort. Steven Gallinger has included themes like Odds ratio and DNA repair in his Cancer study. His studies in Colorectal cancer integrate themes in fields like Breast cancer, Genome-wide association study, Case-control study and Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore;David Goldstein;John Hamm;Arie Figer.
Journal of Clinical Oncology (2007)

5215 Citations

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Catherine A. O’Brien;Aaron Pollett;Steven Gallinger;John E. Dick;John E. Dick.
Nature (2007)

4918 Citations

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Christine M. Ribic;Daniel J. Sargent;Malcolm J. Moore;Malcolm J. Moore;Stephen N. Thibodeau.
The New England Journal of Medicine (2003)

2498 Citations

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras.
Nature (2012)

1910 Citations

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

Robert Gryfe;Hyeja Kim;Eugene T.K. Hsieh;Melyssa D. Aronson.
The New England Journal of Medicine (2000)

1592 Citations

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Daniel J. Sargent;Silvia Marsoni;Genevieve Monges;Stephen N. Thibodeau.
Journal of Clinical Oncology (2010)

1524 Citations

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

John P. Neoptolemos;Deborah D. Stocken;Claudio Bassi;Paula Ghaneh.
JAMA (2010)

1445 Citations

Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray

Yi-an Chen;Mathieu Lemire;Sanaa Choufani;Darci T. Butcher.
Epigenetics (2013)

1303 Citations

MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

Kolja Eppert;Stephen W Scherer;Hilmi Ozcelik;Rosa Pirone.
Cell (1996)

1112 Citations

Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders

Dalila Pinto;Elsa Delaby;Elsa Delaby;Elsa Delaby;Daniele Merico;Mafalda Barbosa.
American Journal of Human Genetics (2014)

914 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven Gallinger

Polly A. Newcomb

Polly A. Newcomb

Fred Hutchinson Cancer Research Center

Publications: 142

Ralph H. Hruban

Ralph H. Hruban

Johns Hopkins University School of Medicine

Publications: 127

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 121

Andrew T. Chan

Andrew T. Chan

Harvard University

Publications: 120

John D. Potter

John D. Potter

Fred Hutchinson Cancer Research Center

Publications: 120

Mark A. Jenkins

Mark A. Jenkins

University of Melbourne

Publications: 119

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 107

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 96

Ian Tomlinson

Ian Tomlinson

University of Edinburgh

Publications: 95

Shuji Ogino

Shuji Ogino

Brigham and Women's Hospital

Publications: 92

Charles S. Fuchs

Charles S. Fuchs

Genentech

Publications: 91

Gloria M. Petersen

Gloria M. Petersen

Mayo Clinic

Publications: 89

Richard S. Houlston

Richard S. Houlston

Institute of Cancer Research

Publications: 89

Hermann Brenner

Hermann Brenner

German Cancer Research Center

Publications: 87

Sapna Syngal

Sapna Syngal

Harvard Medical School

Publications: 82

Eileen M. O’Reilly

Eileen M. O’Reilly

Memorial Sloan Kettering Cancer Center

Publications: 76

Trending Scientists

S. P. Novikov

S. P. Novikov

Russian Academy of Sciences

Robert D. Russell

Robert D. Russell

Simon Fraser University

Ricardo Chavarriaga

Ricardo Chavarriaga

École Polytechnique Fédérale de Lausanne

Shiwen Yang

Shiwen Yang

University of Electronic Science and Technology of China

Dan Kikinis

Dan Kikinis

Liquineq

Alexander McKillop

Alexander McKillop

University of East Anglia

Leslie A. Leinwand

Leslie A. Leinwand

University of Colorado Boulder

Akio Kuroda

Akio Kuroda

Hiroshima University

Aidan Moran

Aidan Moran

University College Dublin

Lila R. Gleitman

Lila R. Gleitman

University of Pennsylvania

Aimo Ruokonen

Aimo Ruokonen

Oulu University Hospital

Mathew R. Williams

Mathew R. Williams

New York University

Amihai Glazer

Amihai Glazer

University of California, Irvine

Anthony H. Gonzalez

Anthony H. Gonzalez

University of Florida

H. Aussel

H. Aussel

University of Paris-Saclay

Something went wrong. Please try again later.